Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 7823

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.
About This Bill
Committee
Latest Action · March 29, 2024
Referred to the Subcommittee on Health.
Introduced
March 26, 2024
Cosponsors (11)
0D 11R
View PDF ↗
SummaryFull TextCommentsAnnotations

Full Text

The official full text of this bill isn’t available inside AllCiv yet. Read it on Congress.gov:

A plain-language summary is on the Summary tab — you can highlight and annotate it there.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.